Filing Details
- Accession Number:
- 0001209191-18-055372
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-17 17:29:03
- Reporting Period:
- 2018-10-15
- Accepted Time:
- 2018-10-17 17:29:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1737287 | Allogene Therapeutics Inc. | ALLO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1296549 | Arie Belldegrun | 210 East Grand Avenue South San Francisco CA 94080 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-10-15 | 35,000 | $18.00 | 35,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-10-15 | 142,248 | $0.00 | 3,710,006 | No | 4 | C | Indirect | See footnote |
Common Stock | Acquisiton | 2018-10-15 | 5,989,352 | $0.00 | 5,989,352 | No | 4 | C | Indirect | See footnote |
Common Stock | Acquisiton | 2018-10-15 | 1,497,336 | $0.00 | 1,497,336 | No | 4 | C | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | C | Indirect | See footnote |
No | 4 | C | Indirect | See footnote |
No | 4 | C | Indirect | See footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Convertible Preferred Stock | Disposition | 2018-10-15 | 27,095 | $0.00 | 142,248 | $0.00 |
Common Stock | Series A Convertible Preferred Stock | Disposition | 2018-10-15 | 1,140,829 | $0.00 | 5,989,352 | $0.00 |
Common Stock | Series A Convertible Preferred Stock | Disposition | 2018-10-15 | 285,207 | $0.00 | 1,497,336 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 488,250 | Indirect | See footnote |
Footnotes
- Each share of Series A Convertible Preferred Stock automatically converted into 5.25 shares of Common Stock upon the closing of the Issuer's initial public offering and had no expiration date.
- The securities are held in the name of the Belldegrun Family Trust.
- The securities are held by VVAG Special Fund LLC (VVAG), of which VVAG LLC is the manager. The reporting person is a Senior Managing Director of VVAG LLC and may therefore be deemed to be the beneficial owner of the common shares held by VVAG. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
- The securities are held by Vida Ventures LLC (Vida), of which VV Manager LLC is the manager. The reporting person is a Senior Managing Director of VV Manager LLC and may therefore be deemed to be the beneficial owner of the common shares held by Vida. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
- The securities are held in the name of Bellco Capital, LLC, of which the reporting person is the manager. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.